![Paul J. Hergenrother](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Paul J.
Hergenrother is the founder of Vanquish Oncology, Inc. and held the title of Director & Chief Scientific Officer.
Postes actifs de Paul J. Hergenrother
| Sociétés | Poste | Début |
|---|---|---|
Vanquish Oncology, Inc.
 Vanquish Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Vanquish Oncology, Inc.
Vanquish Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets | Health Technology |
